Finkielstein, a molecular biologist and an associate professor in the College of Science, will join the Fralin Biomedical Research Institute at VTC on July 1. Her laboratory, which studies how circadian rhythms are involved in breast cancer progression, will move to the Health Sciences and Technology Campus in Roanoke.
Using CRISPR genome editing in zebrafish, scientists with the Fralin Biomedical Research Institute at VTC linked an undiagnosed human disease with a rare genetic mutation that causes craniofacial abnormalities.
New ways to help people resist the siren call of alcohol have not kept pace — which leaves health care providers stuck with the same intervention and rehabilitation options they have been using for decades. But now, Virginia Tech scientists are studying whether people battling alcohol use disorder might gain some relief by “pre-experiencing” the future.
An international research team comprising neuroscientists at Virginia Tech and the University of London revealed brain mechanisms and functional regions that underlie confirmation bias — a phenomenon where people strongly favor information that reinforces their existing opinions over contradictory ones.
With a focus on health sciences and technology, the HS&T Hokie Pitch will involve 30 students who have worked with real-world mentors, selected intellectual property, and created an entrepreneurial plan to develop and commercialize biomedical discoveries.
Elected by their peers and representing a broad range of AAAS “sections,” including statistics, neuroscience, engineering, psychology, and geology/geography, the Virginia Tech professors are among 443 newly elected scholars.
The campus is an expansion of Children’s National that is located on a nearly 12-acre portion of the former Walter Reed Army Medical Center in Washington, D.C., and is set to open its first phase in December 2020.
Michael J. Friedlander, the vice president for health sciences at Virginia Tech and executive director of the Fralin Biomedical Research Institute at VTC, will aid Children’s National efforts to improve understanding of the prevention, treatment, and care of childhood diseases.
Virginia Tech President Tim Sands and Carilion Clinic’s President and Chief Executive Officer Nancy Howell Agee set the tone for the meeting by portraying how both organizations have invested significantly throughout the region and across the commonwealth.
For the second year, Roanoke youth enrolled in Goodwill Industries of the Valley's YouthHQ@Goodwill Science Camp visited the Fralin Biomedical Research Institute at VTC this week. The campers learned about careers in science, microscopy, genetics, viruses, and how a heartbeat happens.
Virginia Tech scientists with the Fralin Biomedical Research Institute at VTC have revealed how different levels of a mitochondrial genetic mutation could cause a rare form of adult-onset diabetes in some people and a childhood-onset progressive neurodegenerative disorder in others.
BRAINBox Solutions, a molecular diagnostics innovator that works extensively with the Fralin Biomedical Research Institute at VTC, announced it has been granted U.S. Food and Drug Administration Breakthrough Device Designation to speed development of a product that includes a blood-based test to aid in prognosis and diagnosis of mild traumatic brain injury.
Researchers at the Fralin Biomedical Research Institute at VTC have revealed how a genetic message to produce healthy heart tissue is altered in the body during stress and aging to contribute to sudden cardiac death.
Addiction researcher Warren Bickel, the Virginia Tech Carilion Behavioral Health Research Professor, will receive the Scientific Translation Award from the Society for the Advancement of Behavior Analysis on Saturday in Chicago, Illinois.